What is the equity of Oncology Pharma this year?
Oncology Pharma has equity of 0 USD this year.
Oncology Pharma Equity 2024
Oncology Pharma Equity
0 USD
Ticker
ONPH
ISIN
US68235J2015
WKN
A2QEWD
In 2024, Oncology Pharma's equity was 0 USD, a 0% increase from the 0 USD equity in the previous year.
Oncology Pharma Aktienanalyse
What does Oncology Pharma do?
Oncology Pharma Inc is a global biotechnology company working on the development of therapies and medications against various types of cancer. The company was founded in the USA in 2011 and is headquartered in Boston, Massachusetts. Its business model is based on developing and marketing medications focused on fighting cancer. The company specializes in targeted therapies, immunotherapies, and combination therapies. Oncology Pharma's products have the potential to revolutionize cancer treatment and improve the lives of millions of people worldwide. Oncology Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Oncology Pharma's Equity
Oncology Pharma's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Oncology Pharma's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Oncology Pharma's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Oncology Pharma's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Oncology Pharma’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Oncology Pharma stock
What was the equity of Oncology Pharma compared to the previous year?
The equity of Oncology Pharma has increased/decreased by 0% decreased compared to the previous year.
What impact does a high equity have on investors of Oncology Pharma?
A high equity is advantageous for investors of Oncology Pharma as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Oncology Pharma?
A low equity can be a risk for investors of Oncology Pharma, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Oncology Pharma affect the company?
An increase in equity of Oncology Pharma can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Oncology Pharma affect the company?
A reduction in equity of Oncology Pharma can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Oncology Pharma?
Some factors that can affect the equity of Oncology Pharma include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Oncology Pharma so important for investors?
The equity of Oncology Pharma is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Oncology Pharma take to change the equity?
To change equity, Oncology Pharma can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Oncology Pharma pay?
Over the past 12 months, Oncology Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oncology Pharma is expected to pay a dividend of 0 USD.
What is the dividend yield of Oncology Pharma?
The current dividend yield of Oncology Pharma is .
When does Oncology Pharma pay dividends?
Oncology Pharma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Oncology Pharma?
Oncology Pharma paid dividends every year for the past 0 years.
What is the dividend of Oncology Pharma?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Oncology Pharma located?
Oncology Pharma is assigned to the 'Health' sector.
Wann musste ich die Aktien von Oncology Pharma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Oncology Pharma from 10/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.
When did Oncology Pharma pay the last dividend?
The last dividend was paid out on 10/2/2024.
What was the dividend of Oncology Pharma in the year 2023?
In the year 2023, Oncology Pharma distributed 0 USD as dividends.
In which currency does Oncology Pharma pay out the dividend?
The dividends of Oncology Pharma are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Oncology Pharma
Our stock analysis for Oncology Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Oncology Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Oncology Pharma Revenue
- Oncology Pharma Net Income
- Oncology Pharma P/E
- Oncology Pharma P/S
- Oncology Pharma EBIT
- Oncology Pharma Dividend
- Oncology Pharma Stocks
- Oncology Pharma Market capitalization
- Oncology Pharma Debt
- Oncology Pharma Liabilities
- Oncology Pharma Equity
- Oncology Pharma AAQS
- Oncology Pharma Employees
- Oncology Pharma ROE
- Oncology Pharma ROA
- Oncology Pharma ROCE
